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ABSTRACT
The leaves of cassava are used as traditional medicine, to treat ringworm, tumor, abscess, conjunctivitis, sores, headaches, 
rheumatism and fever diseases in several countries. Phytochemical investigations showed that flavonoids and Rutin 
constituents of the cassava leaves, berths the need for data as regards safety, effectiveness, toxicity and pharmacokinetics 
for its usage as herbal medicine. The purpose of this research was to observe pharmacokinetic parameters of Rutin in rat 
plasma, after oral administration of cassava leaves extract. Pharmacokinetics indicators for absorption was (Cmax, tmax, 
and AUC0-24h), while elimination was (Ke and t1/2). 14 healthy male Wistar rats were divided into 7 groups (each group 
with 2 rats), after which a single dose (600 mg) of cassava leaves extract was given orally. Thereafter, blood samples 
of the wistar rats were collected and separated at different time intervals (0; 0.5; 1; 2; 4; 6; 12; and 24 h). Using HPLC-
UV-VIS method, the resulting plasma was analyzed for Rutin concentration. The analysis showed Rutin concentration 
at 0 mg/mL (0 h), 0.151 mg/mL (0.5 h), 0.176 mg/mL (1 h), 0.18 mg/mL (2 h), 0.184 mg/mL (4 h), 0.163 mg/mL (6 h), 
0.15 mg/mL (12 h) and 0.1225 mg/mL (24 h). The main pharmacokinetic parameters were; Cmax 0.184 mg/mL recorded 
4 h (tmax) after oral administration; AUC0-24 was 3.583 mg h/mL and t1/2 was 94.54 h. The study concluded that Rutin of 
cassava leaves extract, reached maximum concentration within 4 h after oral administration and was inside in the plasma 
for more than 24 h. Hence, it is recommended to consume cassava leaves extract as herbal medicine, only once a day. 
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ABSTRAK
Daun ubi kayu digunakan sebagai ubat secara tradisi untuk merawat kurap, tumor, abses, konjunktivitis, luka, sakit 
kepala, penyakit sendi dan demam di beberapa negara. Kajian fitokimia mendedahkan flavonoid dan rutin konstituen 
daun ubi kayu memberikan keperluan untuk data mengenai keselamatan, keberkesanan, ketoksikan dan farmakokinetik 
untuk penggunaannya sebagai ubat herba. Tujuan kajian ini adalah untuk melihat parameter farmakokinetik Rutin dalam 
plasma tikus, selepas pemberian oral ekstrak daun ubi kayu. Petunjuk farmakokinetik untuk penyerapan adalah (Cmax, 
tmax, dan AUC0-24h), manakala penghapusan adalah (Ke dan t1/2). Sejumlah 14 tikus Wistar jantan yang sihat dibahagikan 
kepada 7 kumpulan (setiap kumpulan dengan 2 tikus), dan seterusnya satu dos (600 mg) ekstrak daun ubi kayu diberikan 
secara oral. Sampel darah tikus wistar dikumpulkan dan dipisahkan pada jarak masa berlainan (0; 0.5; 1; 2; 4; 6; 12; 
dan 24 jam). Menggunakan kaedah HPLC-UV-VIS, plasma yang dihasilkan dianalisis untuk kepekatan rutin. Analisis itu 
menunjukkan kepekatan Rutin pada 0 mg/mL (0 jam), 0.151 mg/mL (0.5 jam), 0.176 mg/mL (1 jam), 0.18 mg/mL (2 jam), 
0.184 mg/mL (4 jam), 0.163 mg/mL (6 jam), 0.15 mg/mL (12 jam) dan 0.1225 mg/mL (24 jam). Parameter farmakokinetik 
utama adalah; Cmax 0.184 mg/mL mencatatkan 4 jam (tmax) selepas pemberian oral; AUC0-24 adalah 3.583 mg jam/mL 
dan t1/2 adalah 94.54 jam. Kajian itu menyimpulkan bahawa Rutin daun daun ubi kayu, mencapai kepekatan maksimum 
dalam masa 4 jam selepas pengambilan secara oral dan berada di dalam plasma selama lebih dari 24 jam. Oleh itu, 
disarankan untuk mengambil ekstrak daun ubi kayu sebagai ubat herba, hanya sekali sehari.
 
Kata kunci: Ekstrak daun ubi kayu; farmakokinetik; flavonoid; penyerapan
INTRODUCTION
Cassava is one of the shrubs that belong to the family 
Euphorbiaceae, originated from South America and 
continues to spread to Indonesia and across Asia. People 
consume the cassava leaf as vegetable and herb medicine, 
as it contains mineral and electrolyte such as Na, K, Fe, 
Zn, al, Rb, Ba, and Cu (Nugrahaningsih et al. 2017). 
Phytochemical compounds of the cassava leaves extract 
were flavonoids, antocyanin and phenol (Suresh et al. 
2011). 
 Cassava leaves are traditionally used to treat fever, 
rheumatism, headaches, and hemorrhoids. Its herbal 
efficacy is also renowned in Nigeria, for its potential 
to protect people from ringworm, tumor, abscess, 
conjunctivitis, and sores (Miladiyah 2011). Chloroform 
extract of this cassava leaves, also combats bacterial activity 
of V. cholera, Shigella flexneri, S. thyphi and P. auruginosa 
(Zakaria 2006). This herbal leaf possesses anti-bacterial, 
anti-inflammatory, hepatoprotective, anti-cancer and anti-
viral agents’ properties (Kumar & Abhay 2013). Cassava 
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leaves in the form of aqueous extract, methanol and ethanol 
can also inhibit LDL oxidation, chelate cupric ions and 
reduce ferric ions. These biological activities are attributed 
to the presence of several phytochemical compounds, in the 
cassava leaves extract such as anthocyanins, polyphenol 
compounds and flavonoids (Suresh et al. 2011; Wong et 
al. 2006). Rutin, the flavonoid of Cassava leaf, is extracted 
by the HPLC method, which can reduce cholesterol levels 
through its ability to inhibit the formation of endogenous 
cholesterol (Nik Hassan et al. 2014; Tzumbu et al. 2011;). 
In contrast, there has been evidence of large-amount 
consumption of Cassava leaves, causing goiters by 
decreasing iodine absorption (Osman et al. 1993). 
 The advantages and disadvantages of Cassava leaves 
suggest the need of safety and efficacy data as regards its 
use and consumption. Different compounds and substances, 
experience the process of absorption, distribution, 
metabolism and excretion (ADME) differentially, when 
administered orally. The flavonoid compounds from the 
cassava leaves extracts, undergo extensive intestinal 
metabolism after ingestion. Metabolites from this flavonoid 
are transported to the liver, via the hepatic portal vein, 
undergoing further metabolism. The liver metabolites 
are transported to targeted cells and tissues through the 
blood, excreted through the bile after enterohepatic re-
circulation, or eliminated via urine or feces (Thilakarathna 
& Rupasinghe 2013). This metabolite from the flavonoid, 
binds with the protein plasma and in some cases roams free 
in the plasma (Setyawati 2015). 
 The presence of a compound in a plasma, tissue or 
organ, provides information to determine the drug of choice, 
therapeutic management and residual analysis (Shargel et 
al. 2012). There is a dire need for pharmacokinetic data as 
regards to extraction of cassava leaves as a herb, hence this 
study was targeted at understanding the bioavailability of the 
Rutin of the cassava leaves extract after oral administration. 
MATERIALS AND METHODS
EXPERIMENTAL ANIMAL
Fourteen (14) healthy male Wistar rats weighing between 
150-200 g, were taken from Laboratory of Biology, Faculty 
of Mathematics and Natural Sciences, Universitas Negeri 
Semarang. The rats were divided into 7 groups and caged 
based on those groups, they were also fed with food and 
water ad libitum, for an acclimatization period of 5 days 
(Nessa et al. 2013). 
EXPERIMENTAL STUDY
The Wistar rats were placed on 12 h fasting, receiving only 
water ad libitum. After which an oral single dose (600 mg) 
of cassava leaves extract, was administered through their 
drinking water. Blood sample was taken from the orbital 
vein (1.5 mL) and were collected in EDTA tube from each 
group, at time intervals of 0, 0.5, 1, 2, 4, 6, 12 and 24 h after 
oral administration. The blood samples were immediately 
centrifuged at 3000 rpm for 5 min, before the level of 
Rutin plasma was analyzed by HPLC (Kanimozhi 2016; 
Nessa et al. 2013).
DETERMINATION OF RUTIN IN PLASMA
Rutin of cassava leaves extract was determined by a method 
based on Kanimozhi (2016) with some modifications. The 
extraction procedure was carried out with measuring glass 
tubes (10 mL), filled with Plasma aliquot (0.1 mL) and 
shaken with 1.0 methanol for 2 min before filtration by 
membrane filter (45 μm). Afterwards, the methanol extract 
was transferred to dry tube, while a 20 μL filtrate of each 
sample was injected into the chromatographic system. 
CHROMATOGRAPHIC CONDITIONS
The profile of Rutin in rat plasma was analyzed by HPLC 
with a UV detector, while chromatographic separation was 
achieved through a reverse phase C18 column (150 mm and 
4.6 mm, 5 μm pore size). The mobile phase used consisted 
of eluent A acetonitrile (27%) and eluent B (methanol (8%): 
water (87%): acetic acid (5%) (73%), pH adjusted to 3.64 
with acetic acid with a motion phase flow of 0.5 mL/min, 
a column temperature of 25ºC and a wavelength of 347 
nm. The experiment was performed two times, hence the 
mean was used for calculations (Kanimozhi 2016 with 
modification).
CALIBRATION CURVES
The calibration curves were prepared by spiking 
standard solution of Rutin (Merck), into methanol until 
concentration of 12.5, 25, 50, 100, and 200 ppm was 
achieved. After which the Rutin solution was injected into 
the HPLC system for analysis, with the resulting calibration 
curve shown in Figure 1. From the curve results, an 
equation was derived to determine Rutin concentration of 
cassava leaves extract in the plasma. 
DATA ANALYSIS
Rutin concentration in the blood plasma was analyzed 
descriptively, using Microsoft Excel to analyze the 
equation of the calibration curve. The maximum plasma 
concentration Cmax and the time taken to achieve Cmax (tmax), 
were determined directly from the data. Also, AUC
0-24h
 
was calculated using the linear trapezoidal rule, while the 
apparent terminal elimination half-life (t
1/2
) was determined 
using 0.693/Ke (Ke been the slope of the linear regression 
of the plasma metabolite concentration) (Mullen et al. 
2009).
RESULTS AND DISCUSSION
RESULTS
Equation y = bx + a, was used for the linear regression 
analysis, with results showing calibration curve of Rutin, 
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was linear in the range concentration of 12.5, 25, 50, 
100, and 200 ppm. The equation was determined using 
the Microsoft excel platform, whilst the equation was set 
at y = 86398 and x = 600586. The value of x was Rutin 
concentration, while y was the area under the peak of Rutin 
chromatogram (equation curve as shown in Figure 1). The 
equation curve of Figure 1 was used to calculate flavonoid 
concentrations, in the plasma marked with Rutin. 
 The flavonoids Rutin were easily absorbed and 
readily detected in rat plasma, after oral administration 
of the cassava leaves extract to the rat. The mean blood 
concentration versus time curve of the flavonoids, were 
presented in Figure 2. Maximum plasma concentration 
(Cmax) and the time taken to achieve the maximum 
concentration (Tmax), were obtained through visual 
inspection of the plasma concentration versus time curve. 
The Area Under concentration Curve (AUC) from 0 to 
24, was determined by the linear trapezoidal rule, while 
elimination half-life (t1/2) was calculated by 0.693/Ke. 
Mean and S.D were determined for the pharmacokinetic 
parameters and were further were tabulated in Table 1. 
After administration of cassava leaves extract, results 
showed peak concentration (Cmax) was (0.184 ± 0.022 mg/
mL), while Tmax was (4 h). The value of AUC t0-t24 was 
3.583 ± 0.58 mg.h/mL, with t1/2 elimination at 94.54 h after 
oral administration of cassava leaves extract. 
DISCUSSION
Flavonoid was present in the rat plasma, but in conjugated 
or metabolites form. The metabolism of flavonoid involved 
two important organs; the liver, where biotransformation 
enzymes coverts flavonoid or its metabolites into 
conjugated forms such as glucoronides or sulphates 
(Richelle et al. 1999), and the colon, where microorganisms 
degrade unabsorbed flavonoids (Rowland & Tozer 1995). 
The extraction procedure of flavonoids from rat plasma 
was simple and rapid. 
 This study showed that the levels of Rutin plasma, 
appeared the kinetic of flavonoid from 600 mg/mL 
cassava leaves extract, but not its metabolites. Analysis 
of the compound (flavonoid) in the plasma, provided 
TABLE 1. Pharmacokinetic parameters of Rutin plasma after 600 mg                                                      
oral administration of cassava leaves extract
Pharmacokinetic parameters Values Units 
Cmax
Tmax
AUC (Area Under Curve)
t
1/2
0.184 ± 0.022
4 
3.583 ± 0.58
94.54 
mg/mL
h
mg h/mL
h
FIGURE 1. The Calibration curve of Rutin
FIGURE 2. Plasma concentration time profile for Rutin in rats following oral 
administration of 600 mg of cassava leaves extract
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useful information in determining dosage and the timing 
of administration, for its appropriate and safe use as a 
drug. The plasma concentration curve represents the 
net results of two opposite processes; absorption vs 
elimination (Richelle et al. 1999). This time-concentration 
curve signifies the potential for enterohepatic receptor 
flavonoids, as Rutin was present in high amounts in 
cassava leaves extract, hence it was used as a bio-marker 
for the absorption of cassava leaves extract. 
 During the post-absorptive period, whilst absorption 
in the small intestine was declining (due to transit of digest 
and dilution of remaining digest by endogenous material), 
flavonol absorption was however taking place in the large 
intestine (Kanimozhi 2016). After consumption of a single 
dose (600 mg) of cassava leaves extract, flavonoid was 
rapidly absorbed, reaching maximum plasma concentration 
(Cmax) within 4 h after oral administration. This result 
suggested that flavonoid was quickly metabolized by 
the intestinal enzymes and strongly bound to albumin 
(Manach et al. 1999), which might delay their preferential 
movement to the bile for excretion (Jain et al. 2013). The 
Cmax and tmax values suggests circulation of metabolites or 
conjugated flavonoid, as its extravascular administration 
was needed to consider these parameters. Hence, the slow 
drug absorption was characterized by a reduction in Cmax 
and increase of Tmax. (Rowe 2012). These parameters (Cmax 
and tmax) are important, in the development and formulation 
of any new drug or formulation.
 The curve in Figure 2 illustrated the slow and steady 
decrease of Rutin levels after tmax was reached, indicating 
that the flavonoids of cassava leaves extract was still 
present in the plasma at sufficient levels. The value of Ke 
(elimination rate) obtained was smaller (0.00733 hr-1) than 
the value of Ka (absorption rate) (0.01686 hr-1), indicating 
that the process of elimination was slow compared to 
absorption which occurred quickly. The value of Ka and 
Ke was a proportional supporting parameter, because if 
Ka’s value was greater than Ke, the absorption rate will 
be faster than the elimination rate and vice versa. Slow 
elimination implicated that no repetition was required, in 
the application of cassava leaves extract in one day. 
 The peak concentration value (0.184 mg/mL) did 
not decline by half, for up to 24 h (0.125 mg/mL), 
hence the value of t
1/2
 over 24 h was 94.54 h. The total 
absorption of Rutin, as determined from the area under 
the plasma concentration-time curve (AUC) was 3.583 
mg.h/mL (AUC
0-24h
). The AUC is a measurable extent 
of drug bioavailability, reflecting the total amount of 
active drug that reaches systemic circulation (Shargel et 
al. 2012). The AUC values were affected by Cmax and t1/2 
concentration, where the higher concentration for each 
time, the higher value of AUC (Tao et al. 2015). The half-
life indicates the time it takes for the drug to reach half 
concentration of its original content (Setiya et al. 2009), 
furthermore describes the elimination of compounds in 
the plasma, before undergoing a process of distribution 
to a liver-like tissue. This t
1/2
 duration corresponds to the 
Rutin concentrations curve in the plasma, against time 
which indicates a decrease point relative to the axis point. 
Therefore, extra time was allotted after 24 h to monitor the 
flavonoids concentration halve or migrate from the plasma 
to the target tissue. Noticeably, the difference in half-life 
between individuals or animals is caused by absorption, 
metabolism and excretion factors.
 The flavonoids were conjugated to O-glucuronides, 
sulphate ester, o-methyl esters and aglycones in the 
small intestine, liver and colon before its hydrolyzation. 
The conjugated flavonoids are present in the plasma 
(Landete 2012) after oral administration, after crossing 
the intestinal walls to undergo further catabolism. The first 
conjugation of flavonoids occurs in the small intestine, 
after which the resulting metabolites are transported 
to the liver via hepatic portal vein. This metabolites is 
transported to targeted cells and tissues, excreted to the 
bile for enterohepatic re-circulation, or eliminated via 
urine and/or feces (Thilakarathna & Rupasinghe 2013). 
Compounds not absorbed by the intestines will reach the 
colon, for subjection to structural modification by the 
colon microfolia’s (Del Rio et al. 2010). The aglycones 
can also further be catabolized to low molecular weight 
compounds, that can readily be absorbed (Thilakarathna 
& Rupasinghe 2013). 
 Enterohepatic recirculation of metabolites flavonoid, 
also indicates reabsorption by the colon. This process 
further resulting to the second rise of level, might be due to 
the interaction of colonic bacteria on flavonoid glycosides, 
bound to the food matrix such as dietary fiber. The released 
glycosides of flavonoid may be hydrolyzed in colon 
(Aheme & O’Brien 2002), as bacterial glucosides cleave 
the flavonoid ring, resulting in ring fission products such 
as hydroxyl phenylacetic acid (Aheme & O’Brien 2002; 
Mullen et al. 2008). The different absorption phase among 
subject or object may have been as a result of carrier-
mediated transport processes, physiological differences 
such as pH changes along the intestinal tract and distinct 
transit time (Lee & Alyson 2012).
 Flavonoids structure also affects the absorption 
process, as flavonoid aglycone is easily absorbed by the 
intestines, compared to flavonoids glycosides that must 
be converted into aglikon before absorption (Hollman 
2004). Flavonoids were found in blood plasma, but in 
conjugate forms of glucuronide and glucuronide/sulphate 
(Graefe et al. 2001; Piskula & Junji 1998). Absorption of 
flavonoids cassava leaves extract orally is relatively quick, 
compared to flavonoids that are administered in their pure 
form. Similarly, Kanimozhi (2016) study showed that 50 
mg/kg of flavonoids administered orally, reached peak 
time after 6 h. Oral administration of Rutin and quercetin, 
also appears as glucuronide and quarcetine sulfate in 
the plasma after 5 min, indicating rapid absorption 
compared to cassava leaf extract (Yang et al. 2005). 
Giving tea buckling, time to attain peak concentrations 
was however achieved almost par, to oral administration 
of cassava leaves extract at 4.3 ± 1.8 h. However, pure 
routine delivery achieved a longer peak time of 7.0 ± 2.9 
h (Graefe et al. 2001), although its absorption was not 
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rapid compared to the oral administration of the cassava 
leaves extract.
 The absorption between experimental animal and 
individuals, varies depending on the given dosage form, 
anatomy and the physiology of the absorption site. 
Flavonoid absorption process is influenced by several 
things such as physicochemical properties including 
molecular size, shape, lipopholicity, solubility and pKa 
(Kumar & Abhay 2013). In this study, dietary factors 
were minimized through the 12 h fasting placed on the 
rats, giving only drinking water, as food also affects 
absorption rate. Flavonoids (such as quarcetin and Rutin) 
when administered through intravenous pathways cannot 
be detected routinely (Graefe et al. 2001). However, 
oral administration may decrease bioavailability due 
to imperfect absorption or drug interactions with other 
substances (Shargel et al. 2012). The dosage given was in 
liquid form, for easy absorption into the body, as molecular 
factors including differences in activity and synthesis 
of different enzymes are involved in biotransformation 
(Meibohm et al. 2002). The study was limited to rats and 
might significantly differ in humans, due to physiological 
and anatomical variations. Hence, future research should 
be focused on the exact pharmacokinetic parameters in 
human.
CONCLUSION
The flavonoid Rutin of cassava leaves extract absorbed 
into the small intestine, reaches the plasma within 30 min 
after oral administration. Furthermore, the high value 
of Rutin in the plasma indicates the long half-life of the 
extract and its slow elimination. Additionally, general 
variations in pharmacokinetic parameters can be caused 
by physiological factors such as differences in body 
weight, body composition, gastric motility, and associated 
molecular factors. 
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